152 related articles for article (PubMed ID: 25780452)
41. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
[TBL] [Abstract][Full Text] [Related]
42. S100A11 is involved in the progression of colorectal cancer through the desmosome-catenin-TCF signaling pathway.
Zhou J; Murata H; Tomonobu N; Mizuta N; Yamakawa A; Yamamoto KI; Kinoshita R; Sakaguchi M
In Vitro Cell Dev Biol Anim; 2024 Jun; ():. PubMed ID: 38842658
[TBL] [Abstract][Full Text] [Related]
43. SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma.
Zeng Y; Xiao D; He H; He J; Pan H; Yang W; Chen Y; He J
Oncol Lett; 2018 Nov; 16(5):5916-5922. PubMed ID: 30405754
[TBL] [Abstract][Full Text] [Related]
44. A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.
Du HF; Ou LP; Yang X; Song XD; Fan YR; Tan B; Luo CL; Wu XH
Cell Signal; 2014 Mar; 26(3):580-93. PubMed ID: 24316392
[TBL] [Abstract][Full Text] [Related]
45. LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion.
Li Y; Wan X; Wei Y; Liu X; Lai W; Zhang L; Jin J; Wu C; Shao Q; Shao G; Lin Q
Oncol Rep; 2016 Jun; 35(6):3586-92. PubMed ID: 27109588
[TBL] [Abstract][Full Text] [Related]
46. Changes of TIZ expression in epithelial ovarian cancer cells.
Zheng HY; Zheng HY; Zhou YT; Liu EL; Li J; Zhang YM
Asian Pac J Trop Med; 2015 Feb; 8(2):157-61. PubMed ID: 25902032
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK/STAT3 pathway.
Wang A; Jin C; Tian X; Wang Y; Li H
Biol Open; 2019 Sep; 8(9):. PubMed ID: 31477564
[TBL] [Abstract][Full Text] [Related]
48. Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
So WK; Cheng JC; Liu Y; Xu C; Zhao J; Chang VT; Leung PC
Tumour Biol; 2016 Jul; 37(7):9197-207. PubMed ID: 26768617
[TBL] [Abstract][Full Text] [Related]
49. HER2 mediates epidermal growth factor-induced down-regulation of E-cadherin in human ovarian cancer cells.
Cheng JC; Qiu X; Chang HM; Leung PC
Biochem Biophys Res Commun; 2013 Apr; 434(1):81-6. PubMed ID: 23542467
[TBL] [Abstract][Full Text] [Related]
50. [C1q tumor necrosis factor-related protein 6 (CTRP6) inhibits the proliferation and migration of ovarian cancer cells].
Wang L; Liu Z; Duan L; Ma B; Sun Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1664-8. PubMed ID: 26648301
[TBL] [Abstract][Full Text] [Related]
51. LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.
Niu Y; Shao Z; Wang H; Yang J; Zhang F; Luo Y; Xu L; Ding Y; Zhao L
Sci Rep; 2016 May; 6():26112. PubMed ID: 27181092
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of microtubule-associated protein 1 light chain 3B via small-interfering RNA or 3-methyladenine impairs hypoxia-induced HO8910PM and HO8910 epithelial ovarian cancer cell migration and invasion and is associated with RhoA and alterations of the actin cytoskeleton.
Tang Z; Zhang N; Di W; Li W
Oncol Rep; 2015 Mar; 33(3):1411-7. PubMed ID: 25607473
[TBL] [Abstract][Full Text] [Related]
53. [Expression and significance of matriptase in ovarian cancer cells with diverse metastatic potential].
Jiang ZQ; Chen XF; Sun PM; Mao XD; Lin F; Song YY
Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):370-4. PubMed ID: 24016481
[TBL] [Abstract][Full Text] [Related]
54. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5417-22. PubMed ID: 17000675
[TBL] [Abstract][Full Text] [Related]
55. Oncogenic role of LYN in human gastric cancer via the Wnt/β-catenin and AKT/mTOR pathways.
Su R; Zhang J
Exp Ther Med; 2020 Jul; 20(1):646-654. PubMed ID: 32509024
[TBL] [Abstract][Full Text] [Related]
56. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
57. HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.
Wang H; Liu G; Shen D; Ye H; Huang J; Jiao L; Sun Y
Oncol Rep; 2015 Sep; 34(3):1203-10. PubMed ID: 26135141
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA GAS5 inhibits ovarian cancer cell proliferation via the control of microRNA-21 and SPRY2 expression.
Ma N; Li S; Zhang Q; Wang H; Qin H; Wang S
Exp Ther Med; 2018 Jul; 16(1):73-82. PubMed ID: 29896229
[TBL] [Abstract][Full Text] [Related]
59. CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1.
Zhou J; Du Y; Lu Y; Luan B; Xu C; Yu Y; Zhao H
Front Oncol; 2019; 9():802. PubMed ID: 31497537
[No Abstract] [Full Text] [Related]
60. Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression.
So WK; Fan Q; Lau MT; Qiu X; Cheng JC; Leung PC
FEBS Lett; 2014 Nov; 588(21):3998-4007. PubMed ID: 25261255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
